These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 38871479

  • 1. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
    Satoh-Kanda Y, Nakayamada S, Kubo S, Yamagata K, Nawata A, Tanaka H, Kosaka S, Kanda R, Yu S, Fujita Y, Sonomoto K, Tanaka Y.
    RMD Open; 2024 Jun 13; 10(2):. PubMed ID: 38871479
    [Abstract] [Full Text] [Related]

  • 2. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease.
    Nasa Y, Satake A, Tsuji R, Saito R, Tsubokura Y, Yoshimura H, Ito T.
    Front Immunol; 2024 Jun 13; 15():1326066. PubMed ID: 38665907
    [Abstract] [Full Text] [Related]

  • 3. Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
    Hao H, Nakayamada S, Yamagata K, Ohkubo N, Iwata S, Inoue Y, Zhang M, Zhang T, Kanda Satoh Y, Shan Y, Otsuka T, Tanaka Y.
    Arthritis Rheumatol; 2021 Jan 13; 73(1):132-142. PubMed ID: 32720470
    [Abstract] [Full Text] [Related]

  • 4. Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment.
    Shi X, Liao T, Chen Y, Chen J, Liu Y, Zhao J, Dang J, Sun Q, Pan Y.
    Arch Pharm Res; 2024 Jul 13; 47(7):632-644. PubMed ID: 38977652
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 13; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 6. Anti-IL-12/23 p40 antibody attenuates chronic graft-versus-host disease with lupus nephritis via inhibiting Tfh cell in mice.
    Gao Y, Zeng Y, Xue W, Chen Y, Li Q, Bian Z, Tang L, Tang T, Chen C, Gao X, Guo W.
    Biomed Pharmacother; 2020 Sep 13; 129():110396. PubMed ID: 32580046
    [Abstract] [Full Text] [Related]

  • 7. Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways.
    Johnson B, Cheng L, Koenitzer J, Catlett IM, Schafer P.
    Front Immunol; 2024 Sep 13; 15():1437512. PubMed ID: 39403378
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M, Gottschalk C, Uhlmann L, Speer C, Kälble F, Eckstein V, Müller-Tidow C, Meuer S, Mahnke K, Lorenz HM, Zeier M, Steinborn A.
    Arthritis Res Ther; 2018 Dec 18; 20(1):278. PubMed ID: 30563559
    [Abstract] [Full Text] [Related]

  • 9. TYK2: an emerging therapeutic target in rheumatic disease.
    Morand E, Merola JF, Tanaka Y, Gladman D, Fleischmann R.
    Nat Rev Rheumatol; 2024 Apr 18; 20(4):232-240. PubMed ID: 38467779
    [Abstract] [Full Text] [Related]

  • 10. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.
    Le Coz C, Joublin A, Pasquali JL, Korganow AS, Dumortier H, Monneaux F.
    PLoS One; 2013 Apr 18; 8(9):e75319. PubMed ID: 24069401
    [Abstract] [Full Text] [Related]

  • 11. The TYK2-P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets.
    Gorman JA, Hundhausen C, Kinsman M, Arkatkar T, Allenspach EJ, Clough C, West SE, Thomas K, Eken A, Khim S, Hale M, Oukka M, Jackson SW, Cerosaletti K, Buckner JH, Rawlings DJ.
    Front Immunol; 2019 Apr 18; 10():44. PubMed ID: 30740104
    [Abstract] [Full Text] [Related]

  • 12. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8+ T Cells via STAT6-GATA-3 Axis in Systemic Lupus Erythematosus.
    Kato H, Perl A.
    Front Immunol; 2021 Apr 18; 12():635531. PubMed ID: 33763079
    [Abstract] [Full Text] [Related]

  • 13. Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors.
    Ma X, Nakayamada S, Kubo S, Sakata K, Yamagata K, Miyazaki Y, Yoshikawa M, Kitanaga Y, Zhang M, Tanaka Y.
    Ann Rheum Dis; 2018 Sep 18; 77(9):1354-1361. PubMed ID: 29853448
    [Abstract] [Full Text] [Related]

  • 14. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A, Szelinski F, Weißenberg SY, Wiedemann A, Rose T, Lino AC, Dörner T.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3435-3442. PubMed ID: 32357246
    [Abstract] [Full Text] [Related]

  • 15. Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target.
    He L, Liao W, Wang X, Wang L, Liang Q, Jiang L, Yi W, Luo S, Liu Y, Qiu X, Li Y, Liu J, Wu H, Zhao M, Long H, Lu Q.
    Rheumatology (Oxford); 2024 May 03; 63(6):1699-1709. PubMed ID: 37665721
    [Abstract] [Full Text] [Related]

  • 16. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
    Ikeda K, Hayakawa K, Fujishiro M, Kawasaki M, Hirai T, Tsushima H, Miyashita T, Suzuki S, Morimoto S, Tamura N, Takamori K, Ogawa H, Sekigawa I.
    BMC Immunol; 2017 Aug 22; 18(1):41. PubMed ID: 28830352
    [Abstract] [Full Text] [Related]

  • 17. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
    Cheng T, Ding S, Liu S, Li X, Tang X, Sun L.
    Front Immunol; 2021 Aug 22; 12():668760. PubMed ID: 34093566
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
    Cui HD, Qi ZM, Yang LL, Qi L, Zhang N, Zhang XL, Du SY, Jiang Y.
    Clin Exp Immunol; 2011 Aug 22; 165(2):163-71. PubMed ID: 21635228
    [Abstract] [Full Text] [Related]

  • 19. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
    Lin M, Huang L, Huang J, Yu J, Yang X, Yang J.
    J Autoimmun; 2024 May 22; 145():103198. PubMed ID: 38428341
    [Abstract] [Full Text] [Related]

  • 20. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
    Wang L, Zhao P, Ma L, Shan Y, Jiang Z, Wang J, Jiang Y.
    J Rheumatol; 2014 Sep 22; 41(9):1781-92. PubMed ID: 25028374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.